![](/img/cover-not-exists.png)
559 ASN002 a dual oral inhibitor of JAK/SYK signaling improves clinical outcomes and associated cutaneous inflammation in moderate-to-severe atopic dermatitis patients
Guttman-Yassky, E., Pavel, A.B., Song, T., Kim, H., Zammit, D., Toker, S., Rao, N.Volume:
138
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2018.03.567
Date:
May, 2018
File:
PDF, 242 KB
english, 2018